BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30592714)

  • 1. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.
    Negera E; Tilahun M; Bobosha K; Lambert SM; Walker SL; Spencer JS; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007035. PubMed ID: 30592714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
    Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
    Front Immunol; 2018; 9():189. PubMed ID: 29479352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-pathological features of erythema nodosum leprosum: A case-control study at ALERT hospital, Ethiopia.
    Negera E; Walker SL; Girma S; Doni SN; Tsegaye D; Lambert SM; Idriss MH; Tsegay Y; Dockrell HM; Aseffa A; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006011. PubMed ID: 29028793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells in erythema nodosum leprosum maintain anti-inflammatory function.
    Negera E; Bobosha K; Aseffa A; Dockrell HM; Lockwood DNJ; Walker SL
    PLoS Negl Trop Dis; 2022 Jul; 16(7):e0010641. PubMed ID: 35867720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell regulation in Erythema Nodosum Leprosum.
    Negera E; Walker SL; Bobosha K; Howe R; Aseffa A; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006001. PubMed ID: 28991896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.
    Negera E; Walker SL; Bekele Y; Dockrell HM; Lockwood DN
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006121. PubMed ID: 29253897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Efficacy and Safety of Ciclosporin to Prednisolone in the Treatment of Erythema Nodosum Leprosum: Two Randomised, Double Blind, Controlled Pilot Studies in Ethiopia.
    Lambert SM; Nigusse SD; Alembo DT; Walker SL; Nicholls PG; Idriss MH; Yamuah LK; Lockwood DN
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004149. PubMed ID: 26919207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
    Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
    Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction.
    Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V
    Front Immunol; 2024; 15():1366125. PubMed ID: 38715615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasma gondii infection and high levels of IgE are associated to erythema nodosum leprosy (ENL).
    Nascimento LS; de Castro YS; Figueira JA; Souza RDC; da Silva JA; Nahn EP; Peixoto-Rangel AL
    PLoS One; 2024; 19(6):e0300704. PubMed ID: 38865430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement C1q expression in Erythema nodosum leprosum.
    Negera E; Walker SL; Lema T; Aseffa A; Lockwood DN; Dockrell HM
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006321. PubMed ID: 29499046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
    Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
    Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
    Kifayet A; Hussain R
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy.
    Chaitanya S; Lavania M; Turankar RP; Karri SR; Sengupta U
    J Clin Immunol; 2012 Dec; 32(6):1415-20. PubMed ID: 22847545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.